Great article DB. Its just common sense how undervalue this company is with only 35 million O/S, a market cap below projected revenues at this pps and more than 20% of the O/S restricted. A huge market correction is about to happen.
TWEED will be announcing soon beginning of sales to its registered patients which the company has been accepting since February. Beginning of sales was schedule for mid-end of April, so news will be out soon.
I liked this statement made in the comments section, re: people overvaluing companies with no licence or facilities...
"Its like investors would rather take a nondescript brown paper bag that could be full of feces rather than cash that is sitting on the ground, ready for the taking."
News 
Market Data 
Discover 
